Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

FDA approves J&J MedTech’s Impella heart pumps to treat pediatric patients

Johnson & Johnson MedTech partnered with the Advanced Cardiac Therapies Improving Outcomes Network to confirm these devices could safely and effectively treat younger patients. 

artificial intelligence AI in healthcare

Industry Watcher’s Digest

Healthcare AI proponents say the technology will lower healthcare costs. The assertion has its detractors. 

Generative AI for ICU diary keeping

ICU diary-keeping: There’s an AI for that

Intensive care units around the world use daily diaries to track patients’ emotional as well as physical ups and downs. Many find that keeping these helpful resources can add to nurses’ already-heavy workloads. How might generative AI help? 

artificial intelligence AI healthcare

Industry Watcher’s Digest

IT departments are budgeting more for AI in 2025 than for any other single area of investment. 

artificial intelligence AI in healthcare

Stanford HAI lookback: Best-read blog posts of 2024

The year 2023 saw a shift toward open-source AI models, surging investments in generative AI and increasing AI regulation.

IV hospital room intravenous drip solution

Industry Watcher’s Digest

The FDA has finalized its recommendations for getting AI-equipped medical devices approved. 

artificial intelligence AI in healthcare

Providers, payers share actionable experiences involving healthcare AI

A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

Robotic aortic valve replacement (RAVR) is a new minimally invasive treatment option for symptomatic severe aortic stenosis (AS) that uses advanced robotic surgical systems. It has already started gaining momentum as an alternative to both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).

Q&A: Pioneer heart surgeon on the development and long-term potential of robotic aortic valve replacement

It's early for RAVR, but the minimally invasive technique has already started gaining momentum as an alternative to both SAVR and TAVR. We spoke to Vinay Badhwar, MD, one of the world’s leading voices in robotic heart surgery, to learn more.